| Professional Services Industry | Industrials Sector | Engineer Mesha Rizal Sini CEO | ASX Exchange | AU000000AHL5 ISIN |
| ID Country | 91 Employees | 18 Mar 2026 Last Dividend | 10 Jul 2015 Last Split | - IPO Date |
PT Diagnos Laboratorium Utama Tbk is a prominent provider of health services through its network of laboratories across Indonesia. Established in 2007 with its headquarters in Jakarta Pusat, Indonesia, the company has been at the forefront of delivering comprehensive laboratory testing and health services to meet various patient needs. By harnessing advanced diagnostic technologies and expertise, PT Diagnos Laboratorium Utama Tbk plays a critical role in the early detection, diagnosis, and management of diseases, contributing significantly to the health and well-being of Indonesian communities.
Clinical Pathology Laboratory Tests: The company provides a wide range of clinical pathology services, including:
Genomics Laboratory Tests: Specializes in genetic testing across various applications, such as:
Homecare Health Services: Bringing laboratory testing services directly to the patient’s home, offering convenience and privacy. Services include:
SARS-CoV-2 Screening Services: Offering comprehensive screening services for COVID-19, including tests for the omicron variant, to support public health efforts in managing the pandemic.